Research reference only. Research reference only. All compound descriptions are for educational and research purposes. Nothing here constitutes medical advice. Not intended for human use. Always consult a qualified healthcare professional.
What it is
Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from thymic tissue. It is the active ingredient in Zadaxin, FDA-approved for hepatitis B and cancer adjuvant therapy in certain markets — giving it unusually strong clinical research backing. Primary mechanism: activates dendritic cells, enhances NK cell cytotoxicity, promotes Th1 immune polarisation, upregulates MHC class I expression on tumour cells, and demonstrates direct antiviral activity. Research applications range from general immune maintenance (lower dose) to acute viral illness support (higher dose), post-illness recovery, and autoimmune condition research.
Reconstitution & Dosing
| Parameter | Value |
|---|---|
| BAC water | 2ml |
| Each injection | 10iu (maintenance) or 30iu (acute illness) |
| mg per injection | 0.5mg maintenance / 1.5mg acute |
| When | Evening — daily. |
| Duration | 3 months (maintenance) or 1-3 weeks (acute illness) |
ImmuneNK CellsAntiviralTh1Dendritic Cells